Carlayne Jackson, MD, FAAN

Neurologist

Personal Statement:

Carlayne E. Jackson, MD, FAAN, specialist in the treatment and research of neuromuscular disorders and chair of the Department of Neurology in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio, has created research programs and clinics recognized as national Centers of Excellence in neuromuscular treatment. Dr. Jackson is medical director for the South Texas ALS Association Center of Excellence and the MDA (Muscular Dystrophy Association)-ALS Research Center. She has participated in more than 60 multicenter clinical trials and conducted research with the Western ALS Study Group, the Northeast ALS Research Group and the Muscle Study Group, contributing to more than 240 publications.

Jackson served as chief medical officer and assistant dean of ambulatory services from 2009 to 2018, vice chair for faculty development and wellness from 2018 to 2022, and interim chair of neurology since April 2022. A longstanding member and Fellow of the American Academy of Neurology (AAN), she is president-elect of the Board of Directors, co-chaired the ALS Measurement Development Panel and co-authored the ALS Practice Parameters. Dr. Jackson was awarded the AAN Leading in Excellence Mentorship Award in 2017.


Affiliations

President of the American Academy of Neurology (AAN) April 2023 – Present

News



Science Magazine: Texas Neurologist and Professor elected New American Academy of Neurology President

Carlayne Jackson, MD, a specialist in the treatment and research of neuromuscular disorders such as amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease), neurologist and chair of the Department of Neurology at UT Health San Antonio has been elected as the 38th president of the American Academy of Neurology (AAN).